NIH/NIMH Research News Update 11-22-09

On November 22, 2009, in Medical Science, submitted by Christopher Fisher, PhD

The NIH/NIMH Research Update for 11-22-09 brings new information on a potentially groundbreaking drug to treat Fragile X Syndrome that enters a clinical trial phase, brain imaging (MRI) studies that track development of children’s brains, significant grant money to be allocated for Autism research, combined antidepressant and Cognitive Behavioral Therapy (CBT) is most effective treatment for depression in teens, children with Autism Spectrum Disorder who have serious behavioral problems respond best to treatments that include medication plus a structured training program for parents, and more.

Here is the NIH/NIMH Research News Update for 11-22-09:

Enjoy.

CFisher

Related posts that you might enjoy:

About the author

Christopher Fisher, PhD

Dr. Christopher Fisher, Managing Editor for The Behavioral Medicine Report, received his PhD in Clinical Health Psychology & Behavioral Medicine with an emphasis in biopsychosocial approaches to health and wellness, Cognitive Behavioral Therapy (CBT), neurofeedback, biofeedback, cranial electrical stimulation (CES), and QEEG from University of North Texas. He is Board Certified in Neurofeedback (BCIA). Dr. Fisher also received a master’s degree in Clinical Psychology from Texas A&M-Corpus Christi. Dr. Fisher maintains a private practice in Corpus Christi, Texas, and offers individual therapy, group therapy, and neurofeedback. You can learn more here: http://www.christopherfisherphd.com Dr. Fisher enjoys spending time with family, watching sports and movies, and bicycling on rugged terrain.

Visit Authors Website